Sylvie Pichon

Title: Sylvie Pichon: Innovator in Immunogenic Composition

Introduction

Sylvie Pichon is a notable inventor based in Brindas, France. She has made significant contributions to the field of immunology, particularly in the development of vaccines against human cytomegalovirus (HCMV). With a total of 2 patents, her work is recognized for its potential impact on public health.

Latest Patents

Sylvie Pichon's latest patents focus on immunogenic compositions that include HCMV antigens. The first patent describes an immunogenic composition comprising an HCMV gB antigen, an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen, and a Th1-inducing adjuvant. This composition is intended for use as an HCMV vaccine. The second patent also relates to an immunogenic composition that includes the HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a TH1-inducing adjuvant, further emphasizing its application as an HCMV vaccine.

Career Highlights

Sylvie Pichon is currently associated with Sanofi Pasteur Inc., a leading company in the field of vaccines. Her work at Sanofi Pasteur has allowed her to focus on innovative solutions to combat viral infections, particularly HCMV.

Collaborations

Throughout her career, Sylvie has collaborated with notable colleagues, including Pascal Chaux and Rafaela Dumas. These collaborations have contributed to the advancement of her research and the development of effective immunogenic compositions.

Conclusion

Sylvie Pichon is a prominent inventor whose work in immunogenic compositions has the potential to significantly impact vaccine development against human cytomegalovirus. Her contributions to the field are invaluable and highlight the importance of innovation in public health.